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Background: Cathepsin K, a cysteine protease predominantly expressed in osteoclasts, is a major drug target for
the treatment of osteoporosis. Recent findings, however, indicate that cathepsin K is also involved in non-skeletal
metabolism. The development of fibrotic phenotypes in lung and skin is a concern for cathepsin K inhibitors
presently evaluated in clinical trials. Cathepsin K is expressed in lung tissue and has been implicated in lung
fibrosis. However, little is known about the role of cathepsin K in airway development and its effect on TGF-b1
degradation.
Methods: We investigated the effects of cathepsin K-deficiency on alterations in airway integrity, extracellular
matrix composition, and TGF-b1 expression and degradation. Lung homogenates of wild-type and cathepsin K-
deficient mice were used to evaluate their contents of collagen, glycosaminoglycans, and TGF-b1. The accessibility
of TGF-b1 to cathepsin K-mediated degradation was determined in vitro and lung fibroblast proliferations in wild-
type and cathepsin K-deficient cells were evaluated.
Results: Lung airway cathepsin K expression in wild-type mice remained constant between 1 and 6 months of age
and the airway integrity was maintained. In contrast, after 2 months of age, all Ctsk
-/- mice demonstrated increased
airway epithelium thickness by 16-28%, a lower structural airway integrity (1-2 score units lower), elevated
cytokeratin expression of 12%, increased a-actin and vimentin expression by 50% and 70%, increased area of
smooth muscle cells by 15%, elevated hydroxyproline and GAGs content by 20% and 25%, and increased TGF-b1
expression by 25%. TGF-b1 proved an efficient substrate of cathepsin K and TGF-b1 protein content in lung was
increased by a potent cathepsin inhibitor. Lung fibroblasts from Ctsk
-/- mice after TGF-b1 treatment showed
increased proliferation rates, increased levels of TGF-b1 by 30%, and increased ECM secretion.
Conclusion: This study suggests that airway development is partly regulated by cathepsin K and that its expression
contributes to the maintenance of the airway structural integrity. The anticipated use of therapeutic cathepsin K
inhibitors needs to take potential changes in human lungs into consideration.
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Background
Cathepsin K (CatK) is a lysosomal cysteine protease with
potent collagenolytic and elastolytic activities. Its predo-
minant expression in osteoclasts and synovial fibroblasts
defined the protease as an important mediator of bone
resorption and cartilage erosion [1-3]. Selective CatK
inhibitors are presently being evaluated in clinical trials
for osteoporosis [4,5]. However, at least one compound
failed in phase II clinical trials due to severe skin side
effects such as morphea [6]. One major concern of “off-
site” effects of CatK inhibitors are fibrotic alterations in
lung [7]. CatK downregulation is associated with the
development of fibrosis in newborn lungs [8] and
expression levels were significantly lower in lungs of
premature infants developing bronchopulmonary dyspla-
sia [9]. On the other hand, increased levels of CatK
expression have been reported in lungs after bleomycin
and silica treatment and correlated with fibrotic changes
in the lung [10]. These data suggest that CatK plays a
significant role in lung homeostasis.
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way development and remodeling. Changes in airway
structure are common to several pulmonary disorders,
such as asthma and lung fibrosis. Changes are character-
ized by the reconstitution of the epithelium, airway
smooth muscle cell hypertrophy and hyperplasia, abnor-
mal deposition, and distribution of extracellular matrix
(ECM) [11-13]. In airway remodeling, the equilibrium
between production and degradation of ECM is dis-
rupted, leading to a shift in the balance of synthesis and
degradation of ECM and the abnormal deposition of
matrix components. It has been reported that the secre-
tion of growth factors such as TGF-b1a n da l t e r e d
expression of matrix degrading enzymes such as cathe-
psins [14] contribute to structural changes in the ECM.
TGF-b1, one of the most potent regulators of connec-
tive tissue development, increases lung collagen deposi-
tion [15,16]. Elevated levels of TGF-b1 in lung fibroblast
and epithelial cells are associated with the development
of airway remodeling during asthma and correlate with
the thickening of the basement membrane and the
deposition of collagens [17].
Lung fibroblasts are important in generating a struc-
tural framework for the lung and also seem to be active
participants in the remodeling process through prolifera-
tion and the production of specific mediators. It has
been previously shown that epithelial cells, macrophages
and fibroblasts express CatK in the lung [18,19] and
that CatK protects against matrix deposition in bleomy-
cin induced lung fibrosis [20]. Interestingly, the level of
CatK expression in lungs of silica-treated mice was
inversely related to the level of TGF-b1 expression sug-
gesting a link between TGF-b1 and CatK [10].
The aim of this study is to investigate whether CatK
expression directly contributes to the proper airway
development via its ECM-degrading potential and/or
indirectly by controlling TGF-b1 tissue contents.
Methods
Animals
Ctsk
-/- mice were generated as previously reported [21].
10 female Ctsk
-/- a n dw i l dt y p e( W T )m i c e( C 5 7 / B L 6
from Jackson Lab) for each age group (1, 2, 3 and 6
months) were included in the study. Mice were fed a
chow diet (Mouse Diet 5015, containing 11% fat). All
animal experiments were performed in accordance with
protocols approved by the local animal care advisory
committee.
Histological staining and quantitative image analysis
Mice were anesthetized and lungs were perfused with 10
mL ice-cold phosphate-buffered saline (PBS) through
the right ventricle until lung cleared of blood. Then, the
lungs were inflated with 10% formalin through the
trachea, dissected and stored in 10% formalin for 24 h.
Lungs were dehydrated and paraffin-embedded. Sections
(5 μm) were processed for hematoxylin/eosin (H&E)
and Masson trichrome staining. Microscopic images
were acquired with the 20 × objective on a Leica micro-
scope (Leica Microsystems Inc., Wetzlar, Germany) and
evaluated with Openlab software (PerkinElmer, Wal-
tham, Massachusetts, USA). The thickness of airway
epithelium in H&E stained sections was measured from
the base of the airway epithelium to the outer limit of
the reticular lamina of the basement membrane at regu-
lar intervals of 20 μm with a digital micrometer as
described [22]. The integrity of epithelium was assessed
by a score system according to the percentage of length
of the basement membrane with intact epithelium
divided by the total length of the membrane. The intact
epithelium has a single layer, orderly lining and no
pseudo-stratified ciliated epithelium. The score system
corresponds to the following grades: (1) 1, integrity <
15%; (2) 2, 15% ≤integrity < 40%; (3) 3, 40% ≤integrity <
65%; (4) 4, 65% ≤integrity < 85%; (5) 5, 85% ≤integrity.
A3 0μm region extending from the airway basement
membrane into the parenchyma was analyzed for col-
lagen deposition by trichrome staining. The collagen
content was quantified by the percentage of the area of
collagen divided by the perimeter of the basement mem-
brane. At least five distal airways from each mouse lung
section (perimeter of basement membrane less than 950
μm) were selected for quantification.
Hydroxyproline (HYP) assay and glycosaminoglycan (GAG)
assays
Lung tissues were stored at -80°C after harvesting. The
frozen lung was pulverized under liquid nitrogen in a
mortar. The powdered tissue and the cell pellets were
separately incubated with lysis buffer (150 mM NaCl, 10
m MT r i s - H C l ,p H7 . 4 ,1m ME D T A ,1m ME G T A ,1 %
Triton X-100, and 5 mM NaF) containing a protease
inhibitor cocktail (Roche, Mannheim, Germany), and
were further homogenized by ultrasonication. The
supernatants and pellets were separated by spinning at
14,000 g for 20 min at 4°C and protein concentrations
were determined using the Bradford assay. The superna-
tants were kept for immunoblot analysis. The protein
from cell culture media was precipitated by addition of
10% trichloroacetic acid in ice cold acetone. Homoge-
nized lung tissue and the precipitations from the media
were dried under vacuum at 60°C until a constant
weight was obtained. The dried homogenized lung tissue
and precipitations were hydrolyzed by autoclaving at
120°C for 20 min twice in the presence of 2 N NaOH.
The hydrolysate was used for the HYP assay according
to Reddy et al. [23]. After incubation, triplicates of 200
μl of supernatant of the reaction solution were
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nm was measured within 30 min. The results were cal-
culated as μg of HYP per mg dry tissue weight. Total
sulfated glycan content was measured using Blyscan Sul-
fated Glycosaminoglycan Assay kits (Biocolor, Carrick-
fergus, County Antrim, UK) according to the
manufacturer’s instructions. All data were sampled in
triplicates.
Immunohistochemical staining
Sections were incubated with 1% bovine serum albumin
for 30 min at room temperature and subsequently incu-
b a t e da t4 ° Co v e r n i g h tw i t hm o u s ea n t ic a t h e p s i nK
(1H6: 1:100 dilution, produced by Dr. E. Weber), mouse
anti a-smooth muscle actin (1:400, Sigma, Saint Louis,
MO) and goat anti-vimentin (1:150, Sigma). Sections
were then rinsed and incubated with FITC-conjugated
goat anti mouse IgG (1:100, Rockland Immunochemicals
Inc., Gilbertsville, PA) and rabbit anti goat IgG (1:100,
Rockland) for 30 min at room temperature. For con-
trols, the primary antibodies were replaced by non-
immunized goat serum. In the case for CatK immunos-
taining, Ctsk
-/- lung tissue was used. Morphometric
quantification of CatK expression in WT mice airways
was performed by measuring the area of CatK positive
staining inside the airway basement membrane normal-
ized to the perimeter of the basement membrane. Mor-
phometric quantification of airways was performed by
calculating the area of actin and vimentin staining encir-
cling the airway divided by the perimeter of the base-
ment membrane. The size of airway SMCs within the
sampling area was measured by the total area of airway
encircling SMCs (actin staining) divided by the numbers
of airway SMCs. For each mouse, five airways were
analyzed.
Immunoblot analysis
Proteins in lung homogenates and cell lysates were sepa-
rated by SDS-PAGE and were then transferred onto
PVDF membranes. Membranes were incubated with the
appropriate primary antibody overnight at 4°C. The con-
centrations of primary antibodies were as follows:
monoclonal mouse anti-a smooth muscle actin (1:5000,
Sigma), b-actin (1:10000, Sigma), polyclonal goat anti-
vimentin (1:500), rabbit anti-cytokeratin (1:1000, Sigma)
and chicken anti-TGF-b1 (1:850, R&D, Minneapolis,
MN). Blots were then washed with PBS Tween-20
(PBST) for 10 min three times and incubated for 1 h at
room temperature with horseradish peroxidase-conju-
gated anti-mouse (1:3000, Southern Biotech, Birming-
ham, AL), anti-goat (1:3000, Southern Biotech), anti-
rabbit (1:3000, Southern Biotech) and anti-chicken anti-
bodies (1:1500, R&D), respectively, diluted in PBST.
Blots were rinsed 3-times with PBST for 10 min each at
room temperature. Then images of the blots were cap-
tured and analyzed using the Chemigenius imaging sys-
tem (Syngene, Cambridge, UK). All values were
normalized relative to b-actin loading control. Pixel den-
sities were corrected for background staining in the
same membrane.
Cathepsin-dependent TGF-b1 degradation
The pH value of lung homogenates from Ctsk
-/- mice
were adjusted to pH 5.5 by 3 M acetate buffer. Then 2.5
mM dithiothreitol (final concentration) was added to
lung homogenates. The TGF-b1 expression was investi-
gated by two different assays. First, the lung homoge-
nates were incubated with or without human
recombinant CatK (1.15 nM, final concentration) at
room temperature. Human CatK was expressed in
Pichia pastoris as previously described [24]. At 0, 0.5 h,
1 h, 2 h, and 4 h, lung homogenates were transferred
into a new tube containing 10 μM E-64 (final concentra-
tion) and were incubated another 10 min at room tem-
perature. Second, the lung homogenates were incubated
with or without LHVS (10 μM, final concentration) at
650 rpm 28°C for 8 hours. The final products of both
assays were analyzed by immunoblot using chicken anti-
TGF-b1 (R&D) as primary antibody and corresponding
horseradish peroxidase-conjugated rabbit anti-chicken
IgY (R&D) as secondary antibody.
Primary mouse lung fibroblasts (MLFs) culture and
treatment
After anesthesia, the thorax was opened and lungs were
perfused with sterile PBS via the right ventricle until
they were pale. Tissues were minced and suspended in
Dulbecco’s modified Eagle’s medium (DMEM, Invitro-
gen, Carlsbad, CA) containing 0.2% collagenase IV and
0.01% DNase I and incubated with gentle stirring at 37°
C for 30 min. After dispersion with collagenase, isolated
cells were centrifuged, washed, and cultured in DMEM
supplemented with 10% fetal bovine serum (FBS), 1% of
L-glutamine, and penicillin, streptomycin, and fungi-
zone. Cultures were re-fed every other day. All cultures
were evaluated by immunohistochemistry to assess the
expressions of vimentin and cytokeratin. All stained
positively with vimentin and but failed to stain for the
epithelial cell marker, cytokeratin. Fibroblasts between 2
and 3 passages were used for the assays.
Fibroblasts were incubated in 150 mm plates in 10%
FBS/DMEM to reach 70% confluence prior to treatment.
TGF-b1 was reapplied every 24 h. At indicated time
points, the media was remov e df r o mt h ec e l l sa n dc e l l s
were washed twice with ice-cold PBS. In some experi-
ments, at various time points after incubation of cells,
the overlying cell-conditioned medium was removed,
stored in sterile tubes in the presence of a protease
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zen at -80°C until used.
Crystal Violet, MTT and wound healing assays
The Crystal Violet assay (CVA) was used to determine
fibroblast proliferation. Primary lung fibroblasts were
trypsinized and sub-cultured in 24-well plates. Cells
were grown in 10% FBS in DMEM to reach 70% conflu-
ence, and were then starved with serum free DMEM for
24 h. After starvation, FBS concentration was decreased
to 2.5% in the presence or absence of TGF-b1. At
selected time points, the cell layer was washed once
with PBS. Cells were then fixed and stained by 0.5%
crystal violet solution in 25% methanol. After 10 min,
the excess dye was removed by washing with tap water.
Then, the incorporated dye was solubilized in 1% SDS
in PBS, and 200 μl were transferred to a 96-well plate.
To determine the cell numbers in each sample, the opti-
cal density (OD) was measured directly at a wavelength
of 570 nm using a Spectramax Plus reader (Molecular
Devices, Sunnyvale, CA).
For the verification of the CVA, the MTT assay [thia-
zolyl blue, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylter-
trazolium bromide] (Sigma) was performed to determine
fibroblast cell viability and proliferation. On specified
time points, the culture media was removed, and fibro-
blasts were incubated with 0.5 mg/ml MTT solution in
an incubator at 37°C for 3 h. After removing the med-
ium, 600 μl of DMSO was added to each well of a 24-
well plate to solubilize the blue-colored tetrazolium and
the plates were then shaken for 5 min. 200 μlo fM T T
solution were transferred to a 96-well plate. The absor-
bance at 570 nm was monitored using a Spectramax
Plus reader. Data were expressed as percentage of
OD570 nm of TGF-b1 treated sample compared to that
of TGF-b1 untreated samples.
Cell scratch assays were used to determine the
migration and proliferation rate of cells. Equal num-
bers of fibroblasts were seeded onto 12-well plate.
After 90% confluence being reached, cells were rinsed
with PBS and starved in serum free medium for 24 h.
Then three uniform wounds were created per well by
gently scratching a sterile P-200 pipette tip across the
surface of the cultures. Cultures were washed with PBS
to remove cellular debris, and cultures were allowed to
subsequently incubated for 24 h in DMEM supplemen-
ted with 10% FBS. Phase-contrast photomicrographs of
the wounds were obtained at 0 and 24 h after injury.
The wound area was quantified using the Openlab
software. The percentage of the wound healed was
determined by the healing area (0 h wound area sub-
tracted by 24 h wound area) divided by the 0 h wound
area.
TGF-b1 protein determination by ELISA
Total TGF-b1 content in cell culture supernatants and
lung homogenates were determined by ELISA. This
assay was performed according to the manufacturer’s
recommendations (Invitrogen). TGF-b1 concentration
was normalized to total protein as determined by micro
Bradford Protein Assay. Data are expressed as pg TGF-
b1 per mg of protein.
Statistical analysis
Results are expressed as mean ± SE. All image analyses
were performed by two observers blinded to the group
status. Score comparisons between groups were per-
formed using the Chi-test. The significance of differ-
ences of the mean values was calculated using the one-
way ANOVA (t-test). A p value of less than 0.05 was
considered significant.
Results
The expression of CatK in mouse small airways
Using a monoclonal cathepsin K antibody (1H6) we
observed staining for Catk in airway epithelial cells, in
pneumocytes, and likely in infiltrated macrophages (Fig-
ure 1A left panel). Ctsk
-/- derived tissue did not reveal
staining indicating the specificity of the antibody used
(Figure 1A, right panel). The total airway epithelial area
positive for CatK staining per μm of airway perimeter
did show a trend of increased CatK expression from one
to six months (approximately 17% increase in mean
values) but there was no significant increases between
the individual time points (1, 2, 3, 6 months of age; Fig-
ure 1B), indicating a relatively constant CatK expression
in the age groups evaluated.
Effect of CatK deficiency on lung development
The airway epithelium of WT mice is organized in a
single layer displaying an orderly lining (Figure 1C). In
contrast, the airway epithelium of Ctsk
-/- mice of two
months and older is significantly thicker and disorga-
nized (Figure 1C). From month 2 to 6, the epithelium
was about 16-28% thicker in Ctsk
-/- mice when com-
pared to WT littermates (Figure 1D). The integrity of
the airway epithelium is also altered. In some cases,
large zones of epithelium were damaged and disrupted.
Using an epithelium integrity score, we observed that
from 2 months on, Ctsk
-/- mice exhibited integrity
scores 1-2 units below that of WT littermates (p < 0.05)
(Figure 1E). These alterations were also confirmed by
immunoblot analysis evaluating the expression of cyto-
keratin as a marker of epithelial cells. The expression of
cytokeratin was approximately 12% higher in Ctsk
-/-
mice and correlated with the thickness differences
between the two mouse strains (Figure 1F).
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Page 4 of 14Figure 1 Expression of CatK in mouse lungs and its effects on airway epithelium. Representive immunohistochemical staining (A) of a
small airway from a 3 months old WT mouse and an age matched Ctsk
-/- lung tissue sample (original magnification, ×200). (B) Morphometric
analysis of CatK expression in airway epithelium from mice of various ages. The density of CatK expression was normalized to the perimeter of
the basement membrane. Representative H&E staining (C) of small airways from 2 months old WT and Ctsk
-/- mice (original magnification, ×200).
Morphometric analysis shows epithelium thickness (D) and integrity (E) in lung sections from mice of various ages. Representative image and
band analysis (F) of immunoblots show cytokeratin expression in 2 month old lung homogenates. The results revealed that airway epithelium
was increased in thickness and diminished in integrity in Ctsk
-/- mice. Morphometry and image analysis were processed using Openlab software
and Chemigenius system, respectively. All values are expressed as means ± SE for 5 separate experiments. (●(WT) and ◆(Ctsk
-/-) indicate the
number of mouse at a certain score.
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contraction and motility, are marker proteins for asses-
sing the phenotype of SMCs and myofibroblasts [25].
Immunofluorescence analysis showed that the staining
for a-actin and vimentin completely overlapped indicat-
ing that the subepithelial cell layer represents a uniform
cell type (Figure 2A). These cells revealed that the a-
actin/vimetin positive area per micrometer of internal
airway perimeter increased by 50 to 70% (Figure 2B)
reflecting both cell size and cell number increases. The
average size of SMCs was increased by 14-16% in Ctsk
-/-
mice from 2 months to 6 months of age (Figure 2C). All
changes were significant from the age of 2 months (p <
0.05). These changes were also corroborated by immu-
noblot analysis of lung homogenates of 2 month old
mice. The expression of a-actin and vimentin was ele-
vated by 12% and 27% in Ctsk
-/- mice compared to WT
littermates (Figure 2D).
Effect of CatK deficiency on extracellular matrix content
The sub-epithelial layer is composed of ECM compo-
nents such as collagen and GAGs. Changes in lung
Figure 2 Effects of CatK expression on the airway smooth muscle cells. (A) Representative immunofluorescence staining of small airways
from 2 months old WT and Ctsk
-/- mice (original magnification, ×200). Smooth muscle cell layer thickness and cell area in lung sections from
mice of various ages are depicted in panels B and C. (D) Representative image and band intensity analysis data of immunoblots show increased
expression in a-actin and vimentin in 2 months old WT and Ctsk
-/- mice. Morphometry and image analysis were processed using Openlab
software and Chemigenius system, respectively. A/Pbm means the staining area divided by the perimeter of airway basement.
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the phenotype of airway SMCs [26]. To analyze the
ECM content, we first used Masson’s trichrome staining
(Figure 3A) to evaluate the collagen content surround-
ing the airways. Ctsk
-/- mice displayed a significant
increase in collagen deposition which extended through
the epithelial barrier and included the perivasculature,
when compared to same age WT littermates (about 45%
increase from 2 months of age onwards) (Figure 3B).
Secondly, we determined the collagen (HYP) and GAG
contents of whole lung tissue extracts which revealed
significant increases by 20% and 25%, respectively, in
Ctsk
-/- mice when compared to WT littermates from 2
months of age onward (p < 0.05) (Figure 3C, D). These
results suggest a role of CatK in the homeostasis of the
ECM surrounding the airways.
Figure 3 Effects of CatK deficiency on ECM content in lung. (A) Representative Masson trichome staining of small airways from 3 months
old WT and Ctsk
-/- - mice shows collagen distribution around airways (blue color; original magnification, ×200). (B) Morphometric analysis of
collagen distribution surrounding the airways. (C) hydroxyproline (HYP) and (D) glycosaminoglycan (GAG) contents in lung sections from 1, 2, 3,
6 months old mice. The unit (μg/mg) indicates the HYP and GAG contents per mg protein. Morphometric analyses were performed using
Openlab software. A/Pbm means the staining area divided by the perimeter of airway basement.
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To investigate whether CatK expression-associated
changes in airway development depend on a CatK-
dependent regulation of TGF-b1, the levels of TGF-b1
in lung homogenates of 2 and 3 months old mice were
determined by immunoblot and ELISA. Both assays
revealed that the expression of TGF-b1 was significantly
higher (about 25%) in Ctsk
-/- mice than in the WT lit-
termates (p < 0.05, Figure 4A, B). To further elucidate
the interaction between CatK and TGF-b1, we studied
the in vitro digest of lung tissue TGF-b1 by recombinant
CatK. Results depicted in Figure 4C show a 50% degra-
dation of TGF-b1 after 30 min and a complete degrada-
tion after 4 h. The in vitro cleavage specificity of CatK
Figure 4 Effects of CatK expression on TGF-b1 tissue content and secretion. Representative image and band analyses (A) of immunoblots
from 2 months old WT and Ctsk
-/- mice lung homogenates show upregulation of TGF-b1 expression in Ctsk
-/- mice lung. (B) ELISA results show
TGF-b1 secretion is increased in the Ctsk
-/- - mice lung. (C) Relative amount of TGF-b1 in lung homogenate in the presence or absence of
recombinant human CatK (1.15 nM). (D) shows TGF-b1 expression in the absence or presence of the cathepsin inhibitor LHVS. Image analysis
was performed using Openlab software and Chemigenius system, respectively. All immunoblot experiments were performed in triplicates. The
relative protein expression relates to the expression of b-actin.
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actin was insignificantly degraded by CatK in the same
assay (data not shown). We also studied TGF-b1 expres-
sion in presence of LHVS (a pan-cathepsin vinyl sulfone
inhibitor at 10 μM concentration [27]). Results depicted
in Figure 4D show that the TGF-b1 content in lung tis-
s u ew a sm a r k e d l yi n c r e a s e db y5 3 %i nt h ep r e s e n c eo f
LHVS. Taken together, these results suggest that CatK
can significantly influence the TGF-b1 content in lungs.
Effect of CatK-deficiency on mouse lung fibroblast-like
cells (MLFs)
The evaluation of a-actin/vimetin-positive cells sur-
rounding small airways revealed an increase in their
numbers and sizes in Ctsk
-/- mice when compared to WT
littermates (Figure 2B, C). Therefore, we studied the
effect of CatK-deficiency on these cells in vitro regarding
the expression/content of TGF-b1a n dE C Mc o m p o -
nents. MLFs were treated with 5 ng/ml recombinant
human TGF-b1a tt h ei n d i c a t e dt i m ep o i n t sa n dt h e n
TGF-b1 levels were measured by immunoblot analysis
and ELISA. As shown in Figure 5A, the expression of
TGF-b1 protein in Ctsk
-/- MLFs was increased to 130% at
24 hours (p < 0.05) when compared with WT MLFs and
remained at this level until 72 hours (p < 0.01). In condi-
tioned cell culture media, ELISA (Figure 5B) results
revealed similar increases in TGF-b1i nCtsk
-/- mice.
TGF-b1 can induce fibroblasts to undergo differentia-
tion into a myofibroblast phenotype [15]. The differen-
tiated myofibroblast has an increased capacity to express
Figure 5 Effect of CatK expression on TGF-b1 expression and secretion in mouse lung fibroblast (MLFs). (A) shows representative images
of immunoblot and band analysis of TGF-b1 expression in WT and CatK-deficient MLFs at indicated time points. (B) shows ELISA analysis of TGF-
b1 secretion from MLFs into conditioned media. (* p < 0.05, ** p < 0.01 compared with same time point. All experiments were performed three
or four times.)
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Accordingly, we investigated whether alterations of
ECM expression in lung fibroblasts depends on the
expression of CatK. We studied the effect of CatK on
changes of ECM production in MLFs using the HYP
and GAG assays. In the conditioned media, the HYP
content, a marker for collagen, increased after 24 h by
12% and stayed at 130% after 48 and 72 h in Ctsk
-/-
MLFs whereas the GAG content was 12-14% higher in
Ctsk
-/- MLFs than in WT MLFs (Figure 6A, B). The
increases in HYP and GAG in the culture media must
therefore reflect an increase in the expression and/or
secretion of matrix components by Ctsk
-/- MLFs.
Effect of CatK deficiency on TGF-b1 stimulated
proliferation of mouse lung fibroblast (MLF) and wound
healing
To evaluate the role of CatK expression on TGF-b1
mediated cell proliferation of MLFs, we analyzed their
proliferation rates using three different assays: i) CVA,
ii) MTT assay, and iii) cell scratch assay. Cell growth
rates were monitored at 0, 24, 48, and 72 h. The addi-
tion of TGF-b1 increased both WT and Ctsk
-/- fibro-
blasts cell growth rates when compared to the controls.
However, between 24 and 72 h, the proliferative
response of Ctsk
-/- fibroblasts to TGF-b1 was between
20 and 40% higher than that in WT fibroblasts (p <
0.05, Figure 7A, B). These results suggest that CatK
expression can attenuate the cell proliferative effect of
TGF-b1 in MLFs. As expected from the proliferation
data, the wound healing rate for Ctsk
-/- MLFs was about
40% higher than that of WT cells (Figure 7C). These
findings indicated that Ctsk
-/- MLFs migrated and prolif-
erated much faster than WT MLFs.
Discussion
Airway remodeling is observed in various lung diseases
such as asthma and chronic obstructive pulmonary dis-
ease [30]. Besides changes in the cellular composition of
airways, airway remodeling is characterized by an imbal-
ance between excessive extracellular matrix production
and their proteolytic turnover. Proteolytic activities such
Figure 6 HYP and GAG levels in conditioned media of mouse lung fibroblast cultures from WT and CatK-deficient mice (MLFs). (A) HYP
content; (B) GAG content. The unit (μg/mg) indicates HYP or GAG content per mg protein in the media. * p < 0.05, ** p < 0.01 compared with
same time point.
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implicated in lung tissue remodeling [31,32]. More
recently, attention was given to CatK, a papain-like
cysteine protease with a potent collagenase and elastase
activity. Excess as well as deficiency in CatK expression
have been linked to pathological phenotypes. CatK-
deficient mice in the bleomycin-induced lung fibrosis
model display a stronger fibrotic phenotype than their
WT littermates. The phenotype is characterized by a
build-up of collagen fibers due to the lack of the col-
lagenase activity [33]. On the other hand, overexpression
of CatK leads to increased collagen degradation and a
Figure 7 Effects of CatK expression on the migration and proliferation of MLFs. Quantitative analysis of crystal violet assay (CVA) (A) and
MTT assay (B) after MLFs were incubated with TGF-b1 (5 ng/ml) for 0-72 h. (C) phase images of wound healing and wound closure rates (D)
show that CatK-deficient MLFs facilitate wound closure. * p < 0.05, ** p < 0.01 compared with same time point.
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fibrosis [10,20]. It was shown that TGF-b1d o w n - r e g u -
lates the expression of CatK in silica-induced lung fibro-
sis and that the level of CatK expression is inversely
related to the expression of TGF-b1 and the susceptibil-
ity to lung fibrosis [10]. In our present study, we specifi-
cally focused on the effect of CatK deficiency on airway
d e v e l o p m e n ta n ds u g g e s tt h a tt h er o l eo fC a t Ki sn o t
limited to its matrix protein degrading activity but also
affects the proteolytic control of the profibrotic factor,
TGF-b1. Our results demonstrated that CatK deficiency
in mice correlates with increased thickness and reduced
structural integrity of the epithelium, an increase in the
s i z e sa n dn u m b e r so fS M C sa sw e l la sw i t he l e v a t e d
contents of collagen and GAGs. These changes appear
to be in part induced by increased levels of TGF-b1i n
Ctsk
-/- lungs. CatK can reduce the tissue content of
TGF-b1 by its ability to specifically degrade the growth
factor. Furthermore, lung fibroblasts from Ctsk
-/- mice
showed increased migration and proliferation rates.
TGF-b1 expression and ECM production were more
evident in Ctsk
-/- lung fibroblasts than in WT lung
fibroblasts. Interestingly, the specific CatK inhibitor,
balicatib, was reported to increase intact parathyroid
hormone levels in clinical human trials for osteoporosis
by 50% (discussed in [34]) corroborating the potential of
CatK to degrade regulatory factors.
The increased thickness of the epithelium and its loss
of integrity in Ctsk
-/- mice can be understood in several
ways. First, the proliferation of airway epithelium domi-
nates over apoptosis and necrosis [35]. The proliferative
response in the airway epithelium may result in epithe-
lial hyperplasia and thickening resulting in a disorga-
nized epithelium. Cathepsin expression has been
implicated in apoptosis [36] and we have evidence that
overexpression of CatK increases apoptosis rates in lung
fibroblasts (Zhang and Bromme, unpublished data). Sec-
ond, the proliferative underlying cells such as SMCs and
fibroblasts may migrate into the airway epithelium.
Under the stimuli from mediators such as TGF-b1 these
migrating cells may be transformed into myofibroblasts
[15] which will produce more matrix proteins [37].
Third, the predominance in mesenchymal cells (includ-
ing fibroblasts, myofibroblasts, and SMCs) and the lack
of CatK expression may also increase the deposition of
ECM under the basement membrane [38]. The abnor-
mal ECM surrounding the airways may secret more
mediators, which promotes epithelial thickening and
remodeling [39]. The ECM itself may also affect the
growth of airway epithelial cells and influence epithelial
thickness [40]. Taken together, all these changes favor
alterations in the airway structure.
Hypertrophy and hyperplasia of SMCs within the air-
w a yc o n t r i b u t et oc h a n g e si nt h ea i r w a ys t r u c t u r e
[41,42]. This study is the first to report that SMC hyper-
trophy is linked to CatK deficiency. The propensity for
SMCs to grow when CatK is deficient may be linked to
the sensitivity of the SMC to growth factors and altered
pattern of matrix composition [43]. We observed epithe-
lium thickening and loss of structural integrity as well as
abnormal subepithelial collagen deposition within the
airway wall. We also revealed that the level of TGF-b1
protein content in whole lung homogenates has been
elevated in Ctsk
-/- mice. This was consistent with van
den Brûle’s results that the level of CatK expression in
silica-induced lung fibrosis was inversely related to the
level of TGF-b1 expression [10]. The elevated level of
TGF-b1 may induce SMC hypertrophy and hyperplasia
[44]. On the other hand, the increasing ECM deposition
in Ctsk
-/- mice may promote the survival, proliferation,
migration and cytokine synthesis of airway SMCs [45].
TGF-b1 may induce fibroblast differentiation into myofi-
broblasts [46] which results in increased ECM produc-
tion. Then the ECM may subsequently act as a
proliferation and migration factor for fibroblasts, thus
leading to further airway remodeling. In this study, we
have demonstrated that lung homogenates from Ctsk
-/-
mice released more TGF-b1 ,w h i c hi nt u r nl e dt oa n
increase in ECM components such as HYP and GAGs.
The TGF-b1 content in lung homogenates could be also
increased by the addition of a potent CatK inhibitor
such as LHVS. The increased TGF-b1 level was also
accompanied by an increased thickness of the surround-
ing airway smooth muscle layer.
There is evidence that fibroblasts are the main cellular
source of the extracellular collagen matrix deposition
[47,48]. These cells are themselves excellent sources of
CatK [18,33] and TGF-b1 [49]. Under physiological con-
dition, fibroblasts responding to mediators (including
TGF-b1 produced by parenchymal cells) can release
TGF-b1. Our data indicate that CatK can decrease
TGF-b1 tissue levels and therefore control its overall
expression and subsequent secretion. It is tempting to
speculate that CatK acts as a regulator of TGF-b1c o n -
tents produced by fibroblasts. In Ctsk
-/- mice, TGF-b1
levels were elevated. Increased concentrations of TGF-
b1 could then drive airway remodeling both through
cell proliferation and enhanced matrix production.
Although our data clearly suggest that CatK is involved
in TGF-b1 regulation, many questions such as the exact
site of TGF-b1 degradation (extra- or/and intracellular)
as well as the potential proteolytic effect of CatK on the
TGF-receptor remain open.
In this study, we demonstrated that CatK deficiency
mediates airway development and reason that TGF-b1
signaling is partly controlled by the degradation of the
growth factor by CatK. The hypothesis that CatK can
increase TGF-b1 tissue levels is supported by several
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Page 12 of 14lines of evidence. First, we have shown that TGF-b1
levels are elevated in lungs of Ctsk
-/- mice and CatK-
deficient MLFs when compared to the growth factor
levels in WT mice and MLFs. Second, we demonstrated
that CatK can specifically decrease TGF-b1 levels in
Ctsk
-/- lung homogenates and that TGF-b1 expression is
increased in the presence of the cathepsin inhibitor,
LHVS. Third, it has been shown by others that the level
of CatK transcription is strongly upregulated following
silica treatment, and that CatK expression was negatively
correlated with TGF-b1 expression [10]. Altogether,
these results suggested that interactions between CatK
and TGF-b1 contribute to airway development.
In conclusion, we demonstrated that CatK plays a sig-
nificant role in mouse airways. Our findings caution
that anti-CatK targeted therapies such as presently
developed for the treatment of osteoporosis may have
the potential to induce lung remodeling processes.
Further elucidation of the role of CatK in healthy and
diseased airways will provide us with invaluable insight
into the processes that lead to the development of lung
diseases.
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